Connection

JASON ERIKSEN to Peptide Fragments

This is a "connection" page, showing publications JASON ERIKSEN has written about Peptide Fragments.
Connection Strength

0.321
  1. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest. 2003 Aug; 112(3):440-9.
    View in: PubMed
    Score: 0.154
  2. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005 Jul 21; 47(2):191-199.
    View in: PubMed
    Score: 0.044
  3. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. J Biol Chem. 2003 Aug 15; 278(33):30748-54.
    View in: PubMed
    Score: 0.038
  4. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 2001 Nov 08; 414(6860):212-6.
    View in: PubMed
    Score: 0.034
  5. A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease. J Neurochem. 2014 Feb; 128(3):419-30.
    View in: PubMed
    Score: 0.020
  6. Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology. Curr Alzheimer Res. 2013 06; 10(5):507-15.
    View in: PubMed
    Score: 0.019
  7. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. BMC Neurosci. 2007 Jul 24; 8:54.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.